<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00514592</url>
  </required_header>
  <id_info>
    <org_study_id>EJ-0418</org_study_id>
    <nct_id>NCT00514592</nct_id>
  </id_info>
  <brief_title>Additional Neurological Symptoms Before Surgery of the Carotid Arteries - A Prospective Study (ANSYSCAP)</brief_title>
  <acronym>ANSYSCAP</acronym>
  <official_title>Additional Neurological Symptoms Before Surgery of the Carotid Arteries - A Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Umeå University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Umeå University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single center observational study. Observing the time between cerebrovascular symptoms and
      Carotid Endarterectomy (CEA) and patient outcome. An intervention at 17 of the 29 study
      months aimed at reducing the delay and increasing the patient safety. Main outcome is to
      measure the reduction in recurrent stroke with decreased delay to CEA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All patients with a carotid stenosis &gt;50% according to the NASCET-criteria are included. The
      study does not affect the health care the patients receive. The time between symptom and
      surgery is compared to the outcome of the CEA after 45 days, 6 months, 1 year and 5 years. An
      intervention in the form of new practical local and regional guidelines in January 2009 (#17
      of the 29 study months) aimed at reducing the delay and increasing the patient safety.

      PRIMARY AIM:

      To study the risk of Ipsilateral stroke, any stroke, death, any cerebrovascular event, any
      cardiovascular event.

      Two primary analyses:

        1. Ipsilateral ischemic stroke within 90 Days of the presenting event. This analysis is
           aimed at the short term risk of pre-operative stroke. Survival analysis will be used.
           CEA will be used a censor, thus excluding all peri-operative and postoperative strokes.

        2. All primary endpoints within 5 years of the presenting event. This analysis is aimed att
           the long term risk of cardio-vascular morbidity and mortality.

      Secondary analyses:

      1) Same as first primary analysis, but including all stroke as endpoint, not only ipsilateral
      ischemic stroke.

      SECONDARY AIM:

      To attempt to validate different risk and score systems already published by other sources.
      Such as can ABCD2-score be used safely to chose between acute and fast normal screening for
      carotid stenosis?
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ipsilateral Ischemic Stroke Before Carotid Endarterectomy</measure>
    <time_frame>Before CEA</time_frame>
    <description>Ipsilateral ischemic stroke after the presenting event. Only events that occurs within 90 days and before Carotid EndArterectomy (CEA) is used.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Any Stroke Before Carotid Enderarterectomy</measure>
    <time_frame>Before CEA</time_frame>
    <description>Same as primary endpoint, but includes stroke of all types.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">230</enrollment>
  <condition>Carotid Stenoses</condition>
  <arm_group>
    <arm_group_label>All</arm_group_label>
    <description>All patients enter the same group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>New Guidelines</intervention_name>
    <description>New practical guidelines after half of the study aimed at reducing the delay and increasing the patient safety.</description>
    <arm_group_label>All</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with a carotid stenosis &gt;50%, preliminary eligable for CEA in the northern
        region of Sweden
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Carotid stenosis &gt;50% according to NASCET criteria

        Exclusion Criteria:

          -  Not preliminary judged as having an indication for surgery, before an extensive
             investigation is launched. Thus, some patients that will not undergo CEA will be
             included.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per G Wester, Prof.</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Umeå</city>
        <state>Västerbotten</state>
        <zip>90821</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ; Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004 Mar 20;363(9413):915-24.</citation>
    <PMID>15043958</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2007</study_first_submitted>
  <study_first_submitted_qc>August 9, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2007</study_first_posted>
  <results_first_submitted>July 8, 2013</results_first_submitted>
  <results_first_submitted_qc>July 8, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 13, 2013</results_first_posted>
  <last_update_submitted>September 16, 2013</last_update_submitted>
  <last_update_submitted_qc>September 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Umeå University</investigator_affiliation>
    <investigator_full_name>Elias Johansson</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Carotid stenosis</keyword>
  <keyword>Carotid endarterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>All Patients</title>
          <description>All patients enter the same group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="230"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="230"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Patients</title>
          <description>All patients are in the same group</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="230"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="147"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Ipsilateral Ischemic Stroke Before Carotid Endarterectomy</title>
        <description>Ipsilateral ischemic stroke after the presenting event. Only events that occurs within 90 days and before Carotid EndArterectomy (CEA) is used.</description>
        <time_frame>Before CEA</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Patients</title>
            <description>All patients enter the same group</description>
          </group>
        </group_list>
        <measure>
          <title>Ipsilateral Ischemic Stroke Before Carotid Endarterectomy</title>
          <description>Ipsilateral ischemic stroke after the presenting event. Only events that occurs within 90 days and before Carotid EndArterectomy (CEA) is used.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="230"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Stroke Before Carotid Enderarterectomy</title>
        <description>Same as primary endpoint, but includes stroke of all types.</description>
        <time_frame>Before CEA</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Patients</title>
            <description>All patients enter the same group</description>
          </group>
        </group_list>
        <measure>
          <title>Any Stroke Before Carotid Enderarterectomy</title>
          <description>Same as primary endpoint, but includes stroke of all types.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="230"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events not recorded other than the primary and secodary endpoint.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>All Patients</title>
          <description>All patients enter the same group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="230"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="230"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Elias Johansson</name_or_title>
      <organization>Umeå University</organization>
      <phone>+46907850000</phone>
      <email>elias.johansson@neuro.umu.se</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

